Management of Type 2 Diabetes (NICE Guideline)

Summary of NICE guidance on treatment of type 2 diabetes.

NICE recommends that care be tailored to the needs and circumstances of the individual patient, taking into account their personal preferences, comorbidities, risks from polypharmacy, and ability to benefit from long-term interventions.

Download a pdf version of the above chart.
To print: right-click (Windows) or ctrl + click (Macintosh) on the chart and select 'Print...' from the menu.

Adapted from: NICE Clinical Guideline 28 (December 2015) - Type 2 diabetes in adults: management.


KEYWORDS: Canagliflozin | Dapagliflozin | DPP4 inhibitor | Empagliflozin | Exenatide | Glitazones | GLP-1 agonists | Insulin detemir | Insulin glargine | Insulin secretagogues | Linagliptin | Liraglutide | Lixisenatide | Metformin | Monitoring | Pioglitazone | Repaglinide | Saxagliptin | SGLT2 inhibitors | Sitagliptin | Sulfonylureas | Vildagliptin


Read these next

Foot care reminder for canagliflozin prescribing

Healthcare professionals have been reminded of the...


Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.